Additionally, ZNF300 was displayed to be associated with the poor OS of patients with lung adenocarcinoma (Table 2; Figure 2H), confirming that ZNF300 mediated the malignancy of NSCLC. This evidence concerns the gene ZNF300 and non-small cell lung carcinoma.